ArticleAnnals of medicine and surgery (2012)2025

Safety and efficacy of depatuxizumab mafodotin monotherapy or in combination with temozolomide in patients with/without EGFR-amplified recurrent glioblastoma: a systematic review.

Khaled Moghib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.